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Abstract
Background: PGC-1a is a crucial regulator of cellular metabolism and energy homeostasis that functionally acts together
with the estrogen-related receptors (ERRa and ERRc) in the regulation of mitochondrial and metabolic gene networks.
Dimerization of the ERRs is a pre-requisite for interactions with PGC-1a and other coactivators, eventually leading to
transactivation. It was suggested recently (Devarakonda et al) that PGC-1a binds in a strikingly different manner to ERRc
ligand-binding domains (LBDs) compared to its mode of binding to ERRa and other nuclear receptors (NRs), where it
interacts directly with the two ERRc homodimer subunits.
Methods/Principal Findings: Here, we show that PGC-1a receptor interacting domain (RID) binds in an almost identical
manner to ERRa and ERRc homodimers. Microscale thermophoresis demonstrated that the interactions between PGC-1a
RID and ERR LBDs involve a single receptor subunit through high-affinity, ERR-specific L3 and low-affinity L2 interactions.
NMR studies further defined the limits of PGC-1a RID that interacts with ERRs. Consistent with these findings, the solution
structures of PGC-1a/ERRa LBDs and PGC-1a/ERRc LBDs complexes share an identical architecture with an asymmetric
binding of PGC-1a to homodimeric ERR.
Conclusions/Significance: These studies provide the molecular determinants for the specificity of interactions between
PGC-1a and the ERRs, whereby negative cooperativity prevails in the binding of the coactivators to these receptors. Our
work indicates that allosteric regulation may be a general mechanism controlling the binding of the coactivators to
homodimers.
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Introduction
Gene transcription is a highly regulated and dynamic process
orchestrated by large multiprotein complexes harboring different
enzymatic activities. The regulation of gene expression is carried
out by transcription factors (TFs), such as the nuclear receptors
(NRs), the transcriptional activities of which are modulated by
coactivators. In vertebrates, the regulation of cellular metabolism
and energy homeostasis is strongly linked to peroxisome-
proliferator-activated-receptor c coactivator 1a (PGC-1a). PGC-
1a has been implicated in numerous pathogenic conditions,
including diabetes, obesity, neurodegeneration, cardiomyopathy
and ischaemic diseases [1–8]. It has a unique ability to transduce a
wide array of external physiological stimuli such as exposure to
cold, fasting and physical exercise into transcriptional responses.
Notably, PGC-1a induces and coordinates the expression of genes
that regulate mitochondrial biogenesis, respiration and glucose
homeostasis through coactivation of nuclear TFs, including the
estrogen-related receptors ERRa and ERRc, orphan NRs that
interact directly with PGC-1a[9–12]. PGC-1acontains a distinct
set of domains, including a transcriptional activation domain and
the major NR interacting domain (RID) in the N-terminal portion
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and an arginine-serine-rich domain and a RNA binding motif in
the C-terminal portion [3] (Fig. 1). The interaction of PGC-1a
with NRs occurs through leucine-rich interacting motifs which
represent anchoring helices that have the potential to bind to a
hydrophobic groove at the LBD surface [13–15]. Of three such
motifs (L1, L2 and L3) found at the N-terminus of PGC-1a, only
L2 and L3 were demonstrated to interact with NRs. The classical
LxxLL L2 motif was shown to be the major binding site of NRs
such as PPAR, ER, RXR and HNF4 [16–21]. On the other hand,
the motif L3 of sequence LLxYL was initially suggested to function
as the primary site of interaction of PGC-1a with ERRa and
ERRc [10,11,22–24], while motif L2 was shown to participate to a
lesser extent to the interactions with ERR [10,24]. In contrast to
all reported data, the work of Devarakonda et al recently suggested
that the binding of PGC-1a to ERRc LBD is specific and different
from that to ERRa and to other NRs, with motif L2, and not motif
L3, being the major contributor to the interaction with ERRc
[25].
Here, we report the first comparative biophysical and structural
study of the binding of PGC-1a RID to ERRa and to ERRc. We
show that PGC-1a RID binds in an identical manner to ERRa
and ERRc homodimers. Microscale thermophoresis (MST) [26]
experiments provided us unambiguous experimental evidence
demonstrating that the binding of PGC-1a RID is restricted to one
subunit of the ERR homodimer only and involves the high affinity
L3 and the low affinity L2 motifs. Apparent binding affinities
measured by MST for wild-type and mutant PGC-1a RIDs are in
remarkable agreement with values measured by isothermal
titration calorimetry (ITC). NMR studies defined the limits of
PGC-1a RID that interacts with ERR LBD. Consistent with
biophysical data, small-angle X-ray scattering (SAXS) analysis
demonstrates that the PGC-1a/ERRa and PGC-1a/ERRc
complexes have an identical architecture with an asymmetric
binding of PGC-1a RID to one subunit of the receptor
homodimer. The topology of the complex is ERR specific, as
further emphasized by the comparison with data obtained for the
PGC-1a RID bound PPARc/RXRa LBD heterodimer. The
molecular model gives insight into the specificity of the interaction
between PGC-1a and the ERRs and helps understand how this
versatile protein discriminates between ERRs and other NRs.
Results
The Partial Folding of PGC-1a RID upon Binding to ERRa
and ERRc Involves the Same Interacting Region
Several constructs of PGC-1a were designed to encompass the
RID within different boundaries that encompassed motifs L2 and
L3 (RID1, RID2 and NTD in Fig. 1). While sequence alignment
of PGC-1a NTD indicates a high level of sequence conservation
(Fig. S1) the analysis of the amino acid composition and disorder
predictors suggests that PGC-1a NTD can be considered as an
intrinsically disordered protein (IDP), while also retaining some
features of ordered proteins (Fig. S2). The solution properties of
the isolated RID1, RID2 and NTD PGC-1a constructs were
examined experimentally using a range of biophysical character-
ization methods (Fig. S3 and Table S1). The data suggest that
the PGC-1a RID fragments are less compact and more flexible
than globular proteins. Consistent with this, the SAXS analysis
(see File S1) showed that the structural parameters (Rg and
Dmax) of PGC-1a RID1, RID2 and NTD are larger than typical
values estimated for globular proteins and even larger than values
expected for IDPs, suggesting that the PGC-1a RID constructs are
stiffer and thus more extended than classical IDPs (Fig. S3 and
Table S3).
Given the intrinsic disorder properties of PGC-1a NMR was
employed to gain insight into the conformational changes that
PGC-1a RID undergoes upon interaction with ERRa and ERRc
LBD. The measurements on the isolated PGC-1a RID1 and
RID2 indicate that the PGC-1a RID domains are essentially
unstructured, in agreement with the computational and experi-
mental analysis (Figs. S3G-I). On interaction of 15N-labelled
PGC-1a RID1 with either unlabeled ERR LBD, a set of more
Figure 1. Architecture of human PGC-1a and constructs used in this study. PGC-1a contains three LxxLL motifs, two of which (L2 and L3) are
responsible for specific interaction with NRs. The protein constructs used here are PGC-1a RID1 (122–235), PGC-1a RID2 (122–285) and PGC-1a NTD
(1–285) that contain motifs L2 and L3. On the right, the sequence of the His6-tagged PGC-1a RID2 is given showing residues of the L2 and L3 motifs
(bold, blue). Residues identified by NMR as being outside the interacting region are shown in green; residues unambiguously identified as being in
the interacting region are shown in red; additional candidate Ser/Thr residues, affected by binding are underlined.
doi:10.1371/journal.pone.0067810.g001
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than 30 cross-peaks remain. For some portions of PGC-1a RID1,
complex formation leads to line broadening and cross-peaks are
lost from the spectrum. Other portions of the sequence remain
flexible, so line-widths remain narrow and cross-peaks are retained
(Fig. 2). A small number of cross-peaks that are lost upon
interaction with ERRa LBD are shifted upon interaction with
ERRc LBD. This may arise from differences in experimental
conditions or a small intrinsic difference in exchange rates for the
two complexes. The spectra allow us to deduce which portions of
the sequences are intimately involved in complex formation and
which remain unstructured. For this purpose, we did a compar-
ative examination of the cross-peaks that remain, get attenuated or
disappear in the spectra of the bound versus free PGC-1a RID1
and PGC-1a RID2 in interaction with ERRa and ERRc LBD.
We paid special attention to the cross-peaks belonging to glycine,
tryptophan and threonine/serine residues, since these latter were
clearly and unambiguously identified in the spectra (see File S1).
The analysis suggests that binding of PGC-1a involves the
polypeptide chain encompassing G131, G163 and W189 and that
the interaction domain extends as far as T216, while it does not
involve the N-terminal tag or the C-terminal residues. Important-
ly, the NMR data show that the same region of PGC-1a RID is
involved in the interaction with either ERRa or ERRc LBD.
Only One PGC-1a RID Molecule is Bound to the ERRa and
ERRc LBD Homodimer
The stoichiometry of the PGC-1a/ERR complexes for both
ERRa and ERRc was determined using analytical ultracentrifu-
gation in sedimentation velocity mode (SV-AUC). Formation of
the complex was also followed by Tris/CAPS native PAGE
electrophoretic mobility (Fig. S4A). Titration studies were carried
out with increasing molar ratios of PGC-1a RID2 relative to the
ERR LBD homodimer (0.5, 1.4 and 3 molar ratios relative to
ERR dimer concentration). The titration series was analyzed in
terms of diffusion-corrected integral distributions G(S20,w) of the
sedimentation coefficients S20,w, using van Holde-Weischet plots
(Figs. 3A–3B and Table S1) and by a two-dimensional
spectrum analysis (2DSA) coupled to statistical genetic algorithm
Monte-Carlo (GA-MC), where the sedimentation coefficients are
reported together with the frictional ratios in a two-dimensional
graph including statistical confidence intervals (Figs. S4B and
S4C). The analysis of the titration series indicate that the S20,w
value of ERR LBD gets larger upon addition of 0.5 molar
equivalents of PGC-1a RID2, further increases for the ERR
complex with 1.4 molar equivalents of PGC-1a RID2, and stay
unchanged for larger molar ratios. This is further supported by
results from electrospray mass-spectrometry (ESI-MS) analysis
performed under non-denaturing conditions [27,28], indicating
that the PGC-1a RID2/ERR complex consists of one PGC-1a
RID2 molecule per ERR homodimer (Figs. 3C and 3D). Finally,
SEC-MALS analysis on PGC-1a RID2/ERRc LBD led to the
same conclusion (Fig. S4D and Table S1 for the calculated
molecular weights). Altogether, our biophysical studies strongly
indicate that only one PGC-1a RID molecule binds to the
homodimeric ERR LBDs and that the binding of a second
molecule is precluded at physiological concentrations.
A Single ERR Receptor Subunit is Involved in the Binding
of PGC-1a RID
Knowing the stoichiometry, we thus asked the question whether
PGC-1a RID is bound to ERRa and ERRc through interactions
with one subunit or with both subunits. In the former case, it is
thought that the PGC-1a motif L3 is anchored in the canonical
coactivator groove at the surface of the LBD, whereas motif L2
adopts a helical conformation and might form additional contacts
with another part of the surface of the same LBD subunit. In the
latter case, the binding of PGC-1a RID with the two subunits of
the LBD dimer is supposed to involve the motifs L2 and L3, each
interacting with the canonical coactivator groove of either receptor
subunits, as proposed recently for PGC-1a/ERRc LBD [25]. To
discriminate between the binding of PGC-1a RID asymmetrically
on one receptor subunit or both subunits in a sort of cap model, we
Figure 2. PGC-1a RID interacts through an identical region with ERRa and ERRc LBD. NMR spectra of PGC-1a RID fragments in interaction
with (A–B) ERRa LBD and (C) ERRc LBD. 1H-15N HSQC spectra of PGC-1a RID1 (A and C) and RID2 (B) alone (black) and following addition of
unlabeled ERR LBD (red). The sets of attenuated cross-peaks are broadly similar. The additional peaks in RID2 are not affected by binding to either ERR
LBD. Cross-peaks in regions expected for Gly and Ser/Thr residues are boxed and the cross-peak that probably arises from the C-ter residue is
indicated (CT). The cross-peak corresponding to W189 is boxed, showing the broadening or shift upon complex formation.
doi:10.1371/journal.pone.0067810.g002
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employed microscale thermophoresis (MST), a novel, powerful
method for the characterization of protein-protein; protein-DNA
or RNA and protein-ligand interactions [26]. Using a titration
approach, MST allows the affinity constants of interactions to be
determined in the binding equilibrium. In MST experiments, one
of the binding partners is fluorescently labeled at a fixed
concentration (a few tens of nM), while the concentration of the
unlabeled partner is varied from a high concentration, much
above the expected dissociation constant, down to sub-stoichio-
metric concentrations with respect to the labeled protein. For our
experiments, we considered the PGC-1a RID1 wild-type and the
LxxLL mutants L2m and L3m, where the L2 and L3 motifs were
selectively disrupted by alanine point mutations of the leucine
residues inside the motifs. The thermophoresis curves correspond-
ing to the binding of wild-type PGC-1a RID1 to ERRa and
ERRc show a similar profile with two transitions characterized by
a change (positive or negative) of the thermophoresis value. The
two transitions correspond to two distinct binding events of
apparent binding affinity constants KD,1 and KD,2 (Fig. 4, inset).
The first binding event, observed in the low coactivator
concentration range, represents the binding of one molecule of
PGC-1a RID1 to the receptor dimer (Fig. 4). It features a binding
affinity constant KD,1 of the order of a few tens of nM for both
ERRa and ERRc (Table 1). The second transition is observed at
larger coactivator concentration and is characterized by a lower
binding affinity constant KD,2 of the order of mM. This second
thermophoresis jump represents the binding of a second PGC-1a
RID1 molecules to the already formed PGC-1a RID1/LBD
Figure 3. Biophysical characterization of the stoichiometry of the PGC-1a RID2/ERR complexes. A and B. SV-AUC experiments for a
titration series of increasing molar ratio of PGC-1a RID2 with respect to (A) ERRa and (B) ERRc LBD dimer. G(S20,w) distributions are shown over the
entire boundary for free PGC-1a RID2 (green), free ERR LBD (red) and for the titration series with ERR LBD:PGC-1a RID2 ratios 1:0.5 (blue), 1:1.4 (black)
and 1:3 (magenta). The excess of PGC-1a RID2 in the 1:3 data is seen as a shoulder extending to values close to that of free PGC-1a RID2. In the
experiments with ERRc LBD, the concentration of PGC-1a RID2 was overestimated, as can be seen by the faint shoulder of the 1:3 titration data. Thus
the 1:1.4 molar ratio is overestimated and as a consequence the corresponding data approach a limiting value of saturation given by the 1:3 titration
data. C and D. ESI mass spectra recorded under non-denaturing conditions in 200 mM ammonium acetate at pH=7.4 for (C) ERRa LBD (top) and
PGC-1a RID2/ERRa (bottom) and for (D) ERRc LBD (top) and PGC-1a RID2/ERRc complex (bottom). The different charge states of the proteins are
indicated above the peaks and depicted for ERRa and ERRc with green and red dots, respectively and for PGC-1a RID2/ERRa and PGC-1a RID2/ERRc
with magenta and blue triangles, respectively. For the measurements of ERRa complexes, the His6-tag of ERRa LBD was not cleaved, resulting in an
increase of 3766 Da with respect to the molecular weight shown in Table S1.
doi:10.1371/journal.pone.0067810.g003
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dimer that occurs at very large molar excess of coactivator
corresponding to non-physiological concentrations. Disrupting
motif L2 or motif L3 of PGC-1a RID1 by point mutations does
not affect the features of the binding curve as observed for wild-
type PGC-1a RID1. However, the value of the binding affinity
constant KD,1 of these mutants changes with respect to that of wild-
type PGC-1a RID1 (Table 1). In fact, ERRa and ERRc bind
PGC-1a RID1 L2m (only L3 motif is functional) with a slightly
lower binding affinity than the corresponding value for wild-type
PGC-1a RID1. Mutating the L3 motif results in a much larger
decrease in the binding affinity for ERRa and ERRc, suggesting
that motif L3 is the principal interaction motif. However, this also
indicates that motif L2 contributes to the high-affinity binding of
PGC-1a RID1 to ERRs, as demonstarted by the lack of binding of
the double mutant L2mL3m (Table 1). Remarkably, the apparent
KD,1 values calculated from MST experiments compare very well
with KD values obtained independently by isothermal titration
calorimetry (ITC) (Table 1 Table S2 and Fig. S5). Since in our
MST experiments, there are some technical limitations in going to
very high coactivator concentration (mM range), we were not able
to measure the full binding curve for the second binding event, in
particular the plateau region in the upper coactivator concentra-
tion range. Therefore, we could not determine precisely the
binding affinity constant KD,2, but could only suggest an
approximate value based on the initial rise. When we compared
the curves of the L2m mutant and wild-type PGC-1a RID1, we
see no obvious differences in the KD,2 values. However, by
comparing the L3m mutant with the wild-type PGC-1a RID1, we
observe an increase in the KD,2 value for the wild-type which is
roughly the same order of magnitude as the corresponding
increase of KD,1 value observed for the first binding event. These
observations suggest that the second PGC-1a RID1 molecule
binds to the second subunit of ERR homodimer with the same
interaction patterns as that observed for the first PGC-1a RID1
molecule, i.e. main specific interactions through the L3 motif and
secondary interactions carried by the L2 motif on the same
receptor subunit. Altogether, the MST data demonstrate that the
specific binding of the PGC-1a RID1 to ERR at physiological
molar ratios involves a single ERR homodimer subunit.
SAXS Provides Evidence for Similar Induced Partial
Compaction of PGC-1a on Interaction with ERRa and
ERRc
As references for PGC-1a/ERR complexes, scattering data
were first obtained for the isolated ERRa and ERRc LBDs.
Guinier analysis showed a linear behavior for both LBDs with no
sign of unspecific aggregation and allowed the determination of Rg
(Table 2). The experimental SAXS data for ERRc is neatly fitted
by the scattering profile calculated from the crystal structure (PDB
entry 1KV6) using CRYSOL [29] (Fig. 5A) and yields a
symmetrical distance distribution function (Fig.5B). As expected,
the Kratky plot corresponds to a folded globular protein (Fig.
S3F). For ERRa LBD, we have detected a minor fraction of
specific multimerization of the ERR dimers (trimers of dimers).
These hexamers were found to occur in the crystal packing of
ERRa LBD (PDB code: 2PJL) and exist as a minor fraction of the
molecules in solution, as estimated by the program OLIGOMER
[30]. The latter gives an estimate of 0.260.02 volume fraction of
hexamers compared to dimers (PDB code: 3D24), resulting in a
reasonable fit with a chi value of 1.07. The scattering intensities
were then recorded for several PGC-1a RID/ERR complexes
(Fig. 5A) and the structural parameters were derived from the
data (Fig. 5B and Table 2). The Rg and Dmax values of the
PGC-1a RID complexes are significantly smaller than the
corresponding value of the isolated PGC-1a RID molecules
(Table 2 and Table S3). This suggests that PGC-1a RID
undergoes a partial compaction upon binding to its ERR partner
and the similarity in the values of the structural parameters
indicates a similar type of compaction upon complex formation.
The partial induced folding is dependent on the presence of the
two interaction motifs, as suggested by the much larger parameters
observed for the PGC-1a RID1 L2m complex, which are
comparable to the values measured for PGC-1a RID1/PPAR-
RXR (Table 2). For PGC-1a RID2/ERRc LBD, the increase in
Rg and Dmax, compared to those of PGC-1a RID1/ERRc is large
considering for an extension of 50 amino acids. This is in
agreement with the NMR data that showed that this additional
region (PGC-1a 236–285) at the C-terminus is disordered and
does not interact with ERR.
The solution structures of PGC-1a on interaction with ERRa
and ERRc show a highly similar asymmetrical topology.
The scattering curves of PGC-1a RID1/ERRa and PGC-1a
RID1/ERRc are very similar with almost identical Rg and Dmax
values and distribution functions P(r) (Figs. 5A and B). This
strongly suggests that the architecture of the two complexes is alike
with the same molecular determinants of complex formation. The
partial multimerization of ERRa dimers observed in the free state
is suppressed by binding of PGC-1a RID1, as suggested by the
similar structural parameters of the two isotypes of ERR LBD in
complex with PGC-1a RID1. This can be explained by the fact
that PGC-1a is bound close to the hexamerization interface seen in
the crystal packing of isolated ERRa LBD (PDB code: 2PJL). The
molecular envelopes of the ERRa and ERRc in complex with
PGC-1a RID1 exhibit highly similar shape and size with a marked
asymmetry as compared to the crystal structure of ERRc LBD
dimer (Figs. 5C and 6C). From the shape of the molecular
envelopes, it is tempting to position the LBDs in the globular
region and the PGC-1a RID1 in the asymmetric tail of the
envelope. The envelope of PGC-1a RID2/ERRc shows an even
more pronounced asymmetry as compared to that of PGC-1a
RID1/ERRc (Fig. 5C). This supports the positioning of PGC-1a
in the asymmetric tail of the envelope where the extra portion
arises from the 50 additional disordered residues at the C-ter of
PGC-1a RID2. Similarly, the molecular envelope of PGC-1a
NTD/ERRc shows features resembling the envelopes of the
complexes with the shorter PGC-1a RIDs, but with a longer tail
(Fig. 5C). We can thus infer that the N-terminal extension is
positioned asymmetrically on the side of the interacting ERR
subunit.
Although SAXS is not a high resolution structural method, it
provides valuable information on the topological arrangement of
the various subunits composing a molecular complex [31]. When
high-resolution structures of the subunits are available, detailed
models can be constructed by rigid-body modeling, thus giving
insight into the quaternary structure of the complex. Domains or
subunits devoid of high-resolution structure can be either built by
homology modeling or the secondary structure can be predicted
de novo. In the case of PGC-1a RID1/ERRc, the crystal structure
of ERRc LBD is available, whereas no structural data exists for
PGC-1a. We therefore relied on ROBETTA [32], a powerful full-
chain protein structure prediction server based on Rosetta
comparative and ab initio modeling methods, to build model
structures for PGC-1a RID1. A series of models was predicted for
PGC-1a RID1 that all share similar features (Fig.S6). In
particular, the structure of PGC-1a RID1 is predicted to be
mainly composed of loops interspersed with short helical stretches
which notably encompass motifs L2 and L3, in agreement with the
analysis of amino acid composition and the disorder predictions.
Solution Studies of PGC-1a/ERR Complexes
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As a starting model for PGC-1a RID1/ERRc, we used one of the
Robetta models for PGC-1a RID1 and manually positioned it
together with the ERRc LBD structure in the molecular envelope
obtained from experimental scattering data. For this purpose,
motif L3 was anchored into the coactivator binding groove of
ERRc, as observed in crystal structures of ERRa bound to PGC-
1a L3 peptides [33–35]. Given the observations made on the
larger complexes, we placed the N- and C-termini away from the
LBD, but on the same side of the receptor. As a result, motif L2
lies in close vicinity of the receptor body, though the resolution of
SAXS data is not sufficient to assess the validity of this outcome.
Next, rigid-body refinement against the scattering data was
performed using SASREF [36] to adjust the position of PGC-1a
RID1 with respect to the LBD using contacts restraints to keep
motif L3 in the binding site. The resulting models agree pretty well
with the experimental data, but with some mismatch in the q
region close to 0.15 A˚-1. In order to get the best SAXS compatible
model of PGC-1a RID1/ERR LBD, we considered the model
described above as an initial model for molecular dynamics (MD)
simulations. The latter allow artifacts, such as unusual torsion
angles and clashes between non-Ca atoms neglected in the course
of restrained rigid body modeling, to be removed. MD calculations
performed at moderate temperature allow the relaxation of the
conformation of PGC-1a RID1, whereby positional constraints
were imposed solely on the helical segment encompassing L3. As a
result, several conformations were obtained which do not differ
significantly from the starting model (Fig. 6A). In contrast, when
the temperature of the MD trajectory is increased, a larger variety
of conformations is obtained with significant deviation from the
initial model (Fig. 6B). The scattering pattern for each MD
atomic model was computed and compared to the experimental
scattering data. Excellent agreement between the experimental
and computed data is obtained for the atomic models equilibrated
at moderate temperature, including around to q = 0.15 A˚-1
(Figs. 5A and 6A and Table S4). In contrast, clear mismatch
between experimental and computed scattering intensities is seen
for the series of atomic models sampled along the high
temperature MD run, where the starting and the final MD
models are shown in Fig. 6B. The MD analysis supports the
validity of the model built for PGC-1a RID1/ERRc, since even
slight variations of the initial models result in computed scattering
Figure 4. PGC-1a RID1 binding to ERRa and ERRc measured by MST. Unlabeled PGC-1a RID1 protein was titrated into a fixed concentration
of (A) labeled ERRa LBD and (B) labeled ERRc LBD. Top panels: raw thermophoresis data recorded at 20uC using the LED at 50% and IR-laser at 80%.
Bottom panels: isotherms averaged over three consecutive measurements and fitted according to the law of mass action to yield the apparent KD,1.
For the determination of KD,1, the concentration of unlabeled PGC-1a RID1 was varied between 30 mM and 3 nM, while the concentration of ERR LBD
was kept fixed (50 nM). Insets: isotherms for titration series comprising higher unlabeled PGC-1a RID1 concentrations (300 mM to 10 nM) with a fixed
ERR LBD concentration (20 nM), showing the two binding events of binding affinities KD,1 and KD,2.
doi:10.1371/journal.pone.0067810.g004
Table 1. Apparent binding affinities of PGC-1a/ERR LBD from
MST and ITC.
MST ITC
ERR LBD
PGC-1a
RID1 KD,1 (nM) KD,2 (mM) KD (nM)
ERRa Wild type 6266 42 7166
L2m 11969 45 11567
L3m 609654 .290 369666
L2mL3m No binding No binding No binding
ERRc Wild type 4767 80 5363
L2m 9166 84 7166
L3m 517645 .284 223627
L2mL3m No binding No binding No binding
ITC data determined at 20uC and at pH= 7.5 as described in SI.
doi:10.1371/journal.pone.0067810.t001
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curves that deviate from the experimental curve. This result
underlines the existence, in solution, of a well-defined compact
conformation for PGC-1a RID1 bound to ERRc. The validity of
the model built and refined for PGC-1a RID1/ERRc was
examined in the case of PGC-1a RID1/ERRa (Fig. 6D), where
the measured scattering curve agrees very well with the computed
scattering curve for the PGC-1a RID1/ERRc (Fig. 5A and
Table S4), further supporting our initial observations.
Discussion
In our structural and biophysical solution studies, we have
gained considerable insight into the molecular mechanisms
underlying the binding of PGC-1a to ERRa and ERRc. The
NMR analysis suggests that a minimal region of PGC-1a RID
comprising residues G131 to T216 partly folds on interaction with
ERR LBD. Furthermore, biophysical data consistently demon-
strate that the binding of PGC-1a to ERR occurs with a
stoichiometry of one PGC-1a molecule per ERR homodimer.
Crucially, the combination of methods allowed us to demonstrate
that the binding of PGC-1a RID to ERRa and ERRc is identical
and involve only one subunit of the ERR homodimer. The
binding curves for the interaction of PGC-1a RID1 with ERRa or
with ERRc LBD were obtained independently by MST and ITC
and suggest a specific and high affinity binding of one PGC-1a
molecule to the receptor. Furthermore, the MST and ITC analysis
strongly suggested that the principal interaction motif of PGC-1a
RID with both receptors is motif L3, in agreement with all
reported data [10,11,22–24], with the exception of the work of
Devarakonda et al [25] who claim that the binding of PGC-1a to
ERRc LBD is specific and different from that to ERRa and to
other nuclear receptors. These authors interpret hydrogen-
deuterium exchange and ITC experiments as evidence that motif
L2 is the main interaction motif of PGC-1a with ERRc. We
seriously question the validity of their data, since the PGC-1a
construct (136–220) used in these measurements does not include
the whole interaction region with ERRs as determined here by
NMR and motif L2 lies on the extreme of the construct. The
authors reported binding affinities for the binding of wild-type and
mutant PGC-1a RID(136–220) to ERRc LBD of the order of mM
(Table S1 in [25]). These values are of the same order of
magnitude as the values that we measured for the binding to ERR
LBDs of short peptides encompassing either motif L2 (6.1 and
1.2 mM for ERRa and ERRc, resp.) or L3 (4.1 and 1.3 mM for
ERRa and ERRc, resp.), but by far much higher than the values
reported here, using two different methods. This is a strong
indication that their PGC-1a RID (136–220) construct might be
suboptimal for biophysical and structural studies.
The MST studies of the binding of PGC-1a to ERRs have
allowed us to examine a range of concentration ratios between the
two binding partners that cannot be reached with ITC. The
resulting MST data demonstrate that the binding of a second
PGC-1a RID molecule to the ERR homodimer is possible at huge
concentrations of cofactor and with low binding affinity. Remark-
ably, the MST data provide critical and unique information on the
topological arrangement of the PGC-1a RID/ERR LBD com-
plexes, since they demonstrated that the high-affinity binding of
PGC-1a to ERR involves only one ERR subunit. This contrasts
with observations from crystallographic studies of ERR, ER and
RAR LBD homodimers bound to short co-activator peptides,
Table 2. Structural parameters of ERRa, ERRc and their complexes with PGC-1a RIDs from SAXS analysis.
Sample Rg (A˚)* Dmax (A˚)
#,&
Type of
measurement
$
Sample concentration
(mg/mL)
ERRa LBD 25.660.6 8065 SEC 19.0
25.660.6 n.d. Direct 1.9
ERRc LBD 24.560.5 n.d. Direct 1.25
24.460.5 n.d. Direct 1.6
24.560.5 7565 Direct 2.5
24.960.6 n.d. Direct 5.0
PGC-1a RID1/ERRa LBD 29.460.7 10565 Direct 1.8
30.360.7 n.d. Direct 2.2
30.160.7 n.d. Direct 11.0
PGC-1a RID1/ERRc LBD 29.360.7 10365 Direct 1.5
30.160.5 n.d. Direct 7.5
PGC-1a RID1(L2mut)/ERRc LBD 39.760.7 160610 Direct 1.8
41.760.7 n.d. Direct 3.7
PGC-1a RID2/ERRc LBD 32.760.7 n.d. Direct 1.1
33.160.5 n.d. Direct 1.2
33.360.7 13567 Direct 4.5
PGC-1a NTD/ERRc LBD 44.061.5 190610 SEC 8.2
PPARc/RXR LBD 27.260.5 8565 Direct 2.7
PGC-1a RID1/PPARc/RXR LBD 36.061.0 165610 Direct 4.0
*From Guinier analysis.
#From GNOM analysis.
&n.d. non determined.
$
Size-exclusion chromatography(SEC) or Direct injection into SAXS cell (Direct).
doi:10.1371/journal.pone.0067810.t002
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where two peptides are bound to each of the subunits of the
homodimer [33–35,37–39] (Fig. 5C). The presence of two
peptides can be rationalized by the large molar excess used in
the crystallization conditions. However, a careful analysis of these
apparently symmetrical crystal structures reveals a difference in
the mode of binding of the peptides to the homodimer, most likely
reflecting different binding affinities between the two sites. Here,
using PGC-1a RID rather than PGC-1a peptides, our data
provided unambiguous evidence of the asymmetrical binding of
PGC-1a to only one subunit of the ERR homodimers, implying
that allosteric mechanisms prevent the binding of a second PGC-
1a molecule to the ERR homodimer. This cannot be rationalized
Figure 5. SAXS of ERR and ERR in complex with PGC-1a RID. A. Scattering profiles of (from top to bottom) ERRc LBD, PGC-1a RID1/ERRa, PGC-
1a RID1/ERRc, PGC-1a RID2/ERRc and PGC-1a NTD/ERRc. Experimental data are denoted by black dots, the corresponding fits are given as solid lines.
Red fit is computed from the crystal structure of ERRc LBD (PDB entry 1KV6). Blue fits are yielded by the best MD based model of PGC-1a RID1/ERRc.
Green lines represent the fits to the experimental data by the appropriate ab initio bead models. The profiles are arbitrary displaced in logarithmic
scale for better visualization. B. Distance distribution functions of ERRc LBD (red), PGC-1a RID1/ERRa (blue) PGC-1a RID1/ERRc (green), PGC-1a RID2/
ERRc (magenta) and PGC-1a NTD/ERRc (cyan) computed from the X-ray scattering patterns using the program GNOM. C. Ab initio molecular
envelopes from SAXS measurements. The ab initio molecular envelope of ERRc LBD alone is shown in semi-transparent red color together with the
crystal structure of ERRc LBD bound to short peptides derived from the coactivator SCR-1 (PDB code 1KV6). The ab initio molecular envelopes of the
complexes between ERRc LBD and PGC-1a RID1 (green), PGC-1a RID2 (magenta) and PGC-1a NTD (cyan) are depicted highlighting the location of the
additional 50 amino acids at the C-terminal of the PGC-1a RID2 and of the N-terminal extension of PGC-1a NTD. The Ca-trace of ERRc LBD homodimer
and of the coactivator peptides are shown in grey and yellow ribbons, respectively.
doi:10.1371/journal.pone.0067810.g005
Solution Studies of PGC-1a/ERR Complexes
PLOS ONE | www.plosone.org 8 July 2013 | Volume 8 | Issue 7 | e67810
by steric hindrance, since the second binding site is located on the
opposite side of the complex. In the case of the heterodimer RAR/
RXR, it was recently shown that co-activator fragments bind
preferentially to the NR partner of RXR and that binding of a
second molecule to RXR is not favored [40]. However, in the case
of heterodimers, the expected difference in binding affinity to the
two different subunits is sufficient to explain the observed
stoichiometry. The existence of allosteric control in the binding
of ligands and/or coregulators to homodimeric receptors is much
more intriguing, and has already been suggested for homodimeric
RAR and ER [37,39], whereby the binding of a ligand and/or a
coregulator to one of the receptor subunit can impact on the
binding of the ligand and/or a coregulator to the second subunit of
the homodimer. Our data on PGC-1a RID/ERR LBD not only
strongly support the hypothesis of allosteric regulation but
demonstrate its existence. Thus, as a general consequence for
both homo- and heterodimers, the binding of a coregulator to one
subunit of the NR dimer enables further interactions with other
regulatory proteins and may thus lead to fine-tuning of the
transcriptional regulatory response by NRs.
Our scattering data suggest an identical architecture for ERRa
and ERRc complexes, with asymmetrical binding of PGC-1a to
the receptor homodimer. By studying both ERRc and ERRa in
complex with three different constructs of PGC-1a RID, we are
able to achieve unequivocal localization of the N- and C-terminal
extensions of the RID and provide insight into the molecular
mechanism of ERR recognition through motif L3, with motif L2
participating additively to the binding to ERR and contributing to
the KD,1 value (which is lowered by two-fold in the L2m mutant, see
Table 1). Motif L2 may be necessary for stabilizing intra-
molecular interactions allowing the compaction of the molecule
upon interaction with ERR or for interactions with the receptor
outside the canonical coactivator groove. Crystallographic studies
of the complex would help solving this important issue. Our
solution structures are consistent with the crystallographic
observation that the N-terminal flanking residues of motif L3
contributes to the specificity of PGC-1a for ERRs through the
formation of additional contacts with helix H4 and the connecting
loop between helices H8 and H9 [33]. In contrast, the solution
model proposed by Devarakonda et al of PGC-1a (1–220)/ERRc
LBD, in which L2 and L3 each interact with one subunit of the
ERRc homodimer, does not explain any of the binding specificity
of PGC-1a to ERRa and ERRc.
The peculiar binding mode of PGC-1a to one subunit of the
ERRa and ERRc homodimers represents a specific functional
architecture which ought to be different from that obtained with
other NRs, where the L2 motif of PGC-1a is the principal
interaction motif [18–21]. A preliminary SAXS study of PGC-1a
Figure 6. Solution structure of PGC-1a RID1/ERRc and comparison with the ab initio envelope of PGC-1a RID1/ERRa. A. and B.
Schematic cartoon representations of the pseudo-atomic solution structures of the complex PGC-1a RID1/ERRc. The Ca-trace of the PGC-1a RID1
molecule resulting from the rigid-body refinement is shown in light yellow. The N- and C-terminal ends and the positions of motifs L2 and L3, both of
which corresponding to helices, are indicated. The Ca-trace of ERRc LBD dimer is shown in dark grey (PDB entry 1KV6). A. One of the representative
model obtained after relaxation using MD at moderate temperature is shown in blue. B. One of the representative model obtained along the
trajectory of the higher temperature MD run is depicted in red. C and D. Molecular envelopes of the complexes PGC-1a RID1/ERRc (green) and PGC-
1a RID1/ERRa (blue) together with the pseudo-atomic solution structure of PGC-1a RID1/ERRc shown in (A). The orientation of the models in C and D
is identical to that in A and B.
doi:10.1371/journal.pone.0067810.g006
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RID1 bound to PPARc/RXR LBD supports this argument
(Table 2); notably, the much larger increase in Rg and Dmax of
PGC-1a RID1/PPARc/RXR as compared to the values for
PGC-1a RID1/ERR suggests that PGC-1a RID1 does not fold in
a compact manner upon interaction with PPARc, through motif
L2, but retains an extended conformation. This is radically
different from the complexes with ERRs. As a result, the specific
architecture of the PGC-1a/NR building block is expected to
affect the mode of recruitment of other coactivator molecules to
the transcriptional complex, with critical functional consequences.
A question arises as to what extend the symmetry of the ERR
homodimers is broken. PGC-1a may bind to the symmetric
homodimer first, thus determining how the resulting asymmetric
complex interacts with the non-symmetric DNA target. Alterna-
tively, the prior binding of the ERR homodimer to the non-
symmetric DNA target may provide a pre-existing asymmetric
complex with a preferential side for the binding of PGC-1a.
Further work is required to address this issue. Our studies provide
the molecular determinants for the specificity of interactions and
suggest that negative cooperativity is an essential mechanism
controlling the binding of PGC-1a to ERRs. This work indicates
that allosteric regulation may be a general mechanism controlling
the binding of the coactivators to homodimers. Finally, because of
the key role of PGC-1a/ERR in regulating energy homeostasis
and its implication in metabolic diseases, the present study may
provide clues for drug-design targeting the recognition interface
[41].
Materials and Methods
Cloning, Protein Expression and Purification
ERRa-189-423, PGC1a RID1 (wild type and mutants), RID2
and NTD cloned in pET24b and ERRc 229–458 cloned in
pET15b were purified by affinity chromatography, followed by
further polishing on gel filtration columns (GE healthcare).
Nuclear Magnetic Resonance Experiments
1H-15N HSQC spectra were recorded at 600 MHz or
700 MHz and at 10uC on a Bruker DRX600 or Avance III 700
spectrometer equipped with a z-gradient triple-resonance cryo-
probe. 15N-labelled protein samples were at a concentration of
100 mM. The molar excess of non-labelled ERR LBD partner was
about 1.2 per PGC-1a RID molecule. The water signal was
suppressed using the WATERGATE sequence [42]. Data were
processed using NMRPipe [43] and analyzed with NEASY [44].
Small Angle X-ray Scattering
Synchrotron X-ray solution scattering data were collected at the
X33 beamline (DESY, Hamburg) and at the SWING beamline at
SOLEIL Synchrotron (Gif-sur-Yvette, France). The data were
processed and analyzed with the ATSAS suite of SAXS programs
as described in SI Text. The figures of the envelopes and the
solution structures were made using Pymol 1.4.1, Chimera 1.5.3
and the plots were drawn by using Sigmaplot 11.
Microscale Thermophoresis
Experiments were performed using the Monolith NT 115 from
NanoTemper Technologies GmbH and data were analyzed using
NanoTemper Analysis software v.1.4.23. More details can be
found in SI Text.
Isothermal Titration Calorimetry (ITC)
Isothermal titration calorimetry experiments were performed
using a MicroCal iTC200 (GE Healthcare) microcalorimeter.
Data was analyzed with the software Origin 7.0 (OriginLab) using
the one set of sites model. More details can be found in SI Text.
Analytical Ultracentrifigation
Experiments were performed using a Beckman Proteomelab
XL-I ultracentrifuge (Beckman Instruments, CA, USA) with an
An50Ti 8-hole rotor. Data were fit using the UltraScan software
version 9.9 as described in SI Text.
Size-Exclusion Chromatography Coupled to Multi-Angle
and Quasi-Elastic Light Scattering
SEC-MALS/QELS experiments were performed on a multi-
angle light scattering detector (miniDAWN TREOS, Wyatt
Technologies) coupled in-line with SEC and an interferometric
refractometer (Optilab T-rEX, Wyatt Technologies). The analysis
of the data was performed using the ASTRA 5.3.4 software (Wyatt
Technologies).
Electrospray Ionization Mass Spectrometry
ESI-MS measurements were performed on an ESI-TOF mass
spectrometer (MicrOTOF, Bruker Daltonic, Germany). The non-
denaturing mass measurements of the non-covalent complexes
were performed in ammonium acetate (200 mM; pH 7.4) as
described in SI Text.
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